<DOC>
	<DOC>NCT01354704</DOC>
	<brief_summary>The objectives of the study are: o Objective ultrasound: Determine the presence or absence of subclinical DVT in practicing ultrasound-Doppler Day7 and Day35, patients who underwent TKA or THA o Clinical objective To evaluate the efficacy and tolerability clinical Enox ® in these patients compared with the original drug Lovenox ®.</brief_summary>
	<brief_title>Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>man or woman aged over 18 years, admitted to undergo orthopedic total knee or total hip prosthesis requiring the use of enoxaparin 4000 IU for the Prophylaxis. Patient participating in another study. hypersensitivity to enoxaparin sodium, heparin unfractionated heparin or other low molecular weight. Patients at risk of major bleeding or uncontrolled including patients with recent stroke Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>deep veinous thrombosis</keyword>
	<keyword>enoxaparin</keyword>
</DOC>